ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2024
Association between lactulose administration and hypercalcemia in dogs medically managed for hepatic encephalopathy.
Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Identify if lactulose administration is associated with hypercalcemia in dogs medically managed for hepatic encephalopathy due to a portosystemic shunt and measure any magnitude in change of ionized calcium (iCa) or total calcium. Animals: Seventeen client-owned dogs diagnosed with a portosystemic shunt and medically managed with lactulose. Procedure: Total calcium and iCa were measured at Time point 1 (T1), before starting medical management; and Time point 2 (T2), the time of a reassessment after > 3 wk of lactulose administration. Results: There were no statistically significant differences in iCa or total calcium between T1 and T2. Lactulose dose was positively correlated with change in iCa between T1 and T2. Conclusion and clinical relevance: This study did not identify the development of hypercalcemia in a population of dogs treated with lactulose for the management of hepatic encephalopathy. A possible correlation was present between dose of lactulose and change in iCa, and this may represent a dose-dependent association.
Indexed as
Identifiers
39649742PMC11618998What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.